HOME >> MEDICINE >> NEWS
NIAID DNA vaccine for H5N1 avian influenza enters human trial

The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine. The vaccine does not contain any infectious material from the influenza virus.

Unlike conventional flu vaccines, which are developed by growing the influenza virus in hens' eggs and then administered as a weakened or killed form of the virus, DNA-based vaccines contain only portions of the influenza virus' genetic material. Once inside the body, the DNA instructs human cells to make proteins that act as a vaccine against the virus.

VRC Director Gary Nabel, M.D., Ph.D., together with a team of scientists from the VRC recognized the potential for employing new vaccine technology against influenza, a disease for which effective vaccines have long been made, but for which the reliability of supply and manufacturing capacity has been problematic. Dr. Nabel and his colleagues previously have shown the DNA vaccine approach to be effective against influenza viruses in animal models, including highly pathogenic viruses such as the H5N1 strain and the H1N1 virus that caused the deadly 1918 pandemic. The DNA vaccine used in this study is similar to other investigational vaccines evaluated by the VRC that hold promise for controlling other viruses, such as HIV, Ebola, SARS and West Nile.

"An effective H5N1 influenza vaccine would provide a potentially life-saving advance against a global health threat," notes NIAID Director Anthony S. Fauci, M.D. "More broadly, development of this DNA vaccine technology has the potential to improve our production capacity for vaccines to prevent seasonal influenza and other diseases."

"
'"/>

Contact: NIAID News Office
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
3-Jan-2007


Page: 1 2 3

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID media availability: Examining genetic variability of malaria parasite offers insight
3. NIAID awards $4 million to develop anti-radiation treatments
4. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
5. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2018)... ... November 09, 2018 , ... Shared scooter and bike ... data with Remix. The data will be used to help cities manage shared bike ... commitment to data sharing at a lightning panel breakfast event during the National League ...
(Date:11/9/2018)... ... November 09, 2018 , ... Autism Learning Partners ... of autism and other developmental disabilities, is pleased to announce its expansion to ... service gap and alarming rise in Autism Spectrum Disorder (ASD) diagnoses while also ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... , HPH Hospice and LifePath Hospice ) announced today Dean ... Monday, December 3, 2018. Forman will report directly to President and Chief Executive ...
(Date:11/8/2018)... ... November 08, 2018 , ... ... removal and leg vascular skin conditions with Cuter Excel HR™ Laser, a new ... Center and MedSpa has invested in the state-of-the-art Cutera Excel HR™ Laser which ...
(Date:11/8/2018)... ... November 08, 2018 , ... The Salt Lake Tribune named Tranont a top ... is compiled solely on employee feedback gathered through a third-party survey. The anonymous survey ... a few. , “We strive to treat everyone like family here at Tranont,” said ...
Breaking Medicine News(10 mins):
(Date:11/8/2018)... ... 08, 2018 , ... Kaleidoscope Innovation has relocated its primary ... most prosperous business and innovation corridors. Along with that move comes a refreshed ... changes mark a huge milestone for Kaleidoscope Innovation,” said Matt Kornau, CEO. “Our ...
(Date:11/7/2018)... ... November 07, 2018 , ... Modern Acupuncture™, the first ... people in an accessible and affordable delivery, is now available in Westwood, Mass. ... planned in Connecticut, Massachusetts and Rhode Island. , Modern Acupuncture offers affordable memberships ...
(Date:11/7/2018)... ... 07, 2018 , ... Guruji Mahendra Trivedi is an innovative ... practical and spiritual levels. Founder of the Trivedi Effect®. , In a ... B. Jadhav from Dapoli University, India, who discussed the agricultural research projects he ...
Breaking Medicine Technology:
Cached News: